We are live on
!
Find out more
Regenxbio
RGNX
RGNX
86 hedge funds and large institutions have $448M invested in Regenxbio in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 46 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
142% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 19
89% more call options, than puts
Call options by funds: $17K | Put options by funds: $9K
12% more capital invested
Capital invested by funds: $401M → $448M (+$46.4M)
4.9% more ownership
Funds ownership: 68.61% → 73.51% (+4.9%)
1% more funds holding
Funds holding: 85 → 86 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
86
Holders Change
+1
Holders Change %
+1.18%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
46
Reduced
19
Closed
12
Calls
$17K
Puts
$9K
Net Calls
+$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$10.9M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$10.8M |
| 3 |
BlackRock
New York
|
+$8.95M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$8.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.09M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$10.2M |
| 2 |
Millennium Management
New York
|
-$8.17M |
| 3 |
Axa
Paris,
France
|
-$4.37M |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$3.97M |
| 5 |
QF
QVT Financial
New York
|
-$3.73M |
